Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV003403181 | SCV004120867 | likely pathogenic | BBS5-related condition | 2022-08-20 | criteria provided, single submitter | clinical testing | The BBS5 c.412C>T variant is predicted to result in the amino acid substitution p.Arg138Cys. This variant, along with two additional variants in BBS5, was reported in an individual with cone dystrophy (Supplementary Table S2, Carss et al. 2017. PubMed ID: 28041643). A different missense variant affecting the same amino acid residue (c.413G>A, p.Arg138His) was reported in the homozygous state in an individual with Bardet-Biedl syndrome (Sathya Priya et al. 2015. PubMed ID: 24400638). This variant is reported in 0.0057% of alleles in individuals of Latino descent in gnomAD (http://gnomad.broadinstitute.org/variant/2-170349409-C-T). This variant is interpreted as likely pathogenic. |
NIHR Bioresource Rare Diseases, |
RCV000504629 | SCV000598743 | likely pathogenic | Cone dystrophy | 2015-01-01 | no assertion criteria provided | research |